Equities

AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NZD)3.19
  • Today's Change0.03 / 0.95%
  • Shares traded4.40k
  • 1 Year change-8.60%
  • Beta0.5864
Data delayed at least 20 minutes, as of Jun 17 2024 05:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NZD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments124.757.94
Total Receivables, Net414030
Total Inventory494234
Prepaid expenses3.227.106.14
Other current assets, total0.410.740.10
Total current assets1069578
Property, plant & equipment, net3.823.373.36
Goodwill, net------
Intangibles, net534638
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets165148127
LIABILITIES
Accounts payable252212
Accrued expenses4.525.423.97
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.803.034.54
Other current liabilities, total159.148.47
Total current liabilities464029
Total long term debt313536
Total debt323841
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities777565
SHAREHOLDERS EQUITY
Common stock787878
Additional paid-in capital------
Retained earnings (accumulated deficit)9.40(5.2)(16)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.160.230.39
Total equity887362
Total liabilities & shareholders' equity165148127
Total common shares outstanding105105105
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.